Protagenic Therapeutics PTIX Stock
0.37 USD
{{ price }}
-5.626602%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
2.67M USD
LOW - HIGH [24H]
0.36
-
0.44 USD
VOLUME [24H]
158.8K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.27 USD
Protagenic Therapeutics Price Chart
Protagenic Therapeutics PTIX Financial and Trading Overview
| Protagenic Therapeutics stock price | 0.37 USD |
| Previous Close | 1.87 USD |
| Open | 1.92 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 1.85 - 1.92 USD |
| 52 Week Range | 1.25 - 3.32 USD |
| Volume | 5.46K USD |
| Avg. Volume | 10.38K USD |
| Market Cap | 8.21M USD |
| Beta (5Y Monthly) | 0.195422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.27 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
PTIX Valuation Measures
| Enterprise Value | 817.44K USD |
| Trailing P/E | N/A |
| Forward P/E | -3.2672415 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2795409 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Protagenic Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.195422 |
| 52-Week Change | -38.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.32 USD |
| 52 Week Low | 1.25 USD |
| 50-Day Moving Average | 1.93 USD |
| 200-Day Moving Average | 2.08 USD |
PTIX Share Statistics
| Avg. Volume (3 month) | 10.38K USD |
| Avg. Daily Volume (10-Days) | 3.61K USD |
| Shares Outstanding | 4.33M |
| Float | 1.86M |
| Short Ratio | 0.85 |
| % Held by Insiders | 51.64% |
| % Held by Institutions | 9.09% |
| Shares Short | 5.36K |
| Short % of Float | 0.14% |
| Short % of Shares Outstanding | 0.11% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.15% |
| Return on Equity (ttm) | -38.47% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -2911492 USD |
| Diluted EPS (ttm) | -0.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.65M USD |
| Total Cash Per Share (mrq) | 1.77 USD |
| Total Debt (mrq) | 369.13K USD |
| Total Debt/Equity (mrq) | 5.76 USD |
| Current Ratio (mrq) | 6.122 |
| Book Value Per Share (mrq) | 1.481 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1935083 USD |
| Levered Free Cash Flow (ttm) | -930584 USD |
Profile of Protagenic Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 149 Fifth Avenue |
| ZIP | 10010 |
| Phone | 212 994 8200 |
| Website | https://www.protagenic.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Q&A For Protagenic Therapeutics Stock
What is a current PTIX stock price?
Protagenic Therapeutics PTIX stock price today per share is 0.37 USD.
How to purchase Protagenic Therapeutics stock?
You can buy PTIX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Protagenic Therapeutics?
The stock symbol or ticker of Protagenic Therapeutics is PTIX.
Which industry does the Protagenic Therapeutics company belong to?
The Protagenic Therapeutics industry is Biotechnology.
How many shares does Protagenic Therapeutics have in circulation?
The max supply of Protagenic Therapeutics shares is 7.24M.
What is Protagenic Therapeutics Price to Earnings Ratio (PE Ratio)?
Protagenic Therapeutics PE Ratio is now.
What was Protagenic Therapeutics earnings per share over the trailing 12 months (TTM)?
Protagenic Therapeutics EPS is -1.27 USD over the trailing 12 months.
Which sector does the Protagenic Therapeutics company belong to?
The Protagenic Therapeutics sector is Healthcare.
Protagenic Therapeutics PTIX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 19627.44 USD — |
-0.28
|
7.47B USD — | 19575.21 USD — | 19969.17 USD — | — - | 7.47B USD — |
| NASDAQ HealthCare IXHC | 1022.81 USD — |
-0.5
|
— — | 1021.97 USD — | 1039.72 USD — | — - | — — |
- {{ link.label }} {{link}}